Glioblastoma (GBM) is known as an intractable, highly heterogeneous tumor encompassing multiple subclones, each supported by a distinct glioblastoma stem cell (GSC). The contribution of GSC genetic and transcriptional heterogeneity to tumor subclonal properties is debated. In this study, we describe the systematic derivation, propagation, and characterization of multiple distinct GSCs from single, treatment-naive GBMs (GSC families). The tumorigenic potential of each GSC better correlates with its transcriptional profile than its genetic make-up, with classical GSCs being inherently more aggressive and mesenchymal more dependent on exogenous growth factors across multiple GBMs. These GSCs can segregate and recapitulate different histopathological aspects of the same GBM, as shown in a paradigmatic tumor with two histopathologically distinct components, including a conventional GBM and a more aggressive primitive neuronal component. This study provides a resource for investigating how GSCs with distinct genetic and/or phenotypic features contribute to individual GBM heterogeneity and malignant escalation.

Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas / De Bacco, F.; Orzan, F.; Crisafulli, G.; Prelli, M.; Isella, C.; Casanova, E.; Albano, R.; Reato, G.; Erriquez, J.; D'Ambrosio, A.; Panero, M.; Dall'Aglio, C.; Casorzo, L.; Cominelli, M.; Pagani, F.; Melcarne, A.; Zeppa, P.; Altieri, R.; Morra, I.; Cassoni, P.; Garbossa, D.; Cassisa, A.; Bartolini, A.; Pellegatta, S.; Comoglio, P. M.; Finocchiaro, G.; Poliani, P. L.; Boccaccio, C.. - In: CELL REPORTS. - ISSN 2211-1247. - 42:8(2023). [10.1016/j.celrep.2023.112816]

Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas

Poliani P. L.
Penultimo
;
2023-01-01

Abstract

Glioblastoma (GBM) is known as an intractable, highly heterogeneous tumor encompassing multiple subclones, each supported by a distinct glioblastoma stem cell (GSC). The contribution of GSC genetic and transcriptional heterogeneity to tumor subclonal properties is debated. In this study, we describe the systematic derivation, propagation, and characterization of multiple distinct GSCs from single, treatment-naive GBMs (GSC families). The tumorigenic potential of each GSC better correlates with its transcriptional profile than its genetic make-up, with classical GSCs being inherently more aggressive and mesenchymal more dependent on exogenous growth factors across multiple GBMs. These GSCs can segregate and recapitulate different histopathological aspects of the same GBM, as shown in a paradigmatic tumor with two histopathologically distinct components, including a conventional GBM and a more aggressive primitive neuronal component. This study provides a resource for investigating how GSCs with distinct genetic and/or phenotypic features contribute to individual GBM heterogeneity and malignant escalation.
2023
cancer stem cell
CP: Cancer
GBM-PNC
gene amplification
gene mutation
glioblastoma
glioblastoma stem-like cell
growth factor
receptor tyrosine kinase
tumor heterogeneity
File in questo prodotto:
File Dimensione Formato  
PIIS2211124723008276.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 9.42 MB
Formato Adobe PDF
9.42 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/162387
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact